Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-25
1996-12-17
Gitomer, Ralph J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 85, 514247, 514258, A61K 3152, A61K 3150
Patent
active
055853803
ABSTRACT:
The specification discloses methods for modulating cellular metabolism in a subject, modulating being desirable to mitigate a condition of the subject. Disclosed methods include processes for administering to said subject an effective amount of a compound of the formula ##STR1## wherein one and only one of R.sup.1 and R.sup.3 is a straight-chain or branched-chain .omega.-hydroxyalkyl (5-8C), or is a branched-chain (.omega.-1)-hydroxyalkyl (5-8C), or is an (.omega.-1)-oxoalkyl (5-8C), or is an (.omega., .omega.-1) or (.omega.-1, .omega.-2)-dihydroxyalkyl (5-8C), or is an alkenyl substituent (5-8C), and the other is alkyl (1-12C) optionally containing one or two non-adjacent oxygen atoms in place of C.
REFERENCES:
patent: 3373433 (1968-03-01), Mohler et al.
patent: 3422107 (1969-01-01), Mohler et al.
patent: 3737433 (1973-06-01), Mohler
patent: 4515795 (1985-05-01), Hinze
patent: 4576947 (1986-03-01), Hinze
patent: 4636507 (1987-01-01), Kreutzer
patent: 4696932 (1987-09-01), Jacobson
patent: 4880791 (1988-11-01), Waitmann et al.
patent: 4935233 (1990-06-01), Bell et al.
patent: 4965271 (1990-10-01), Mandell
patent: 4978332 (1990-12-01), Luck
patent: 5068236 (1991-11-01), Suzuki et al.
patent: 5096906 (1992-03-01), Mandell
patent: 5112827 (1992-05-01), Saunders
patent: 5118500 (1992-06-01), Hanel et al.
patent: 5288721 (1994-02-01), Klein
Martindale 28th Ed Edited by Reynolds 1982 The Pharmaceutical Press, London, p. 1629.
The Merck Index, 11th Ed Budavari (Editor) 1989 Merck & Co. Rahway NJ #7092, 2315, 7852, 5181.
Bailly S., Effects of Quinolones on Tumor Necrosis . . . Int J. Immunopharmac 12 #1 pp. 31-36 1990.
Bianco J. A. Combined Pharmacologic Blockade of TNF . . . Exp Hematology 19 #6 p. 553 Jul. 1991.
Bursten, Rapid Activation of Phosphatidate . . . Biochem 30 #25 pp. 6195-6203 1991.
Crumplin, Aspects of Chemistry in the Development . . . Rev of Infectious Dis 10 Suppl pp. 52-59 1988.
Han, Dexamethasone & Pentoxifylline Inhibit . . . J Exp Med 172 pp. 391-394 1990.
Hooper, Mode of Action of the Quinolone . . . Rev of Infectious Dis 11, Supp 5 pp. S902-S911 1989.
Strieter, Cellular & Molecular Regulation of TNF . . . Biochem & Biophys Res Comm 155, 3, pp. 1230-1236 1988.
Tracey, Cachectin/TNF, Lancet pp. 1122-1126 1989.
Anderson et al., Science, vol. 250, pp. 979-982, "Binding of SH2 Domains of Phospholipase C.gamma.1, GAP, and Src to Activated Growth Factor Receptors", 1990.
Barbacid, Mariano, Ann. Rev. Biochem., vol. 56, pp. 779-827, "ras Genes", 1987.
Bazan, Fernando J., Neuron, vol. 7, pp. 197-208, "Neuropoietic Cytokines in the Hematopoietic Fold", 1991.
Berridge, Michael J., Ann. Rev. Biochem., vol. 56, pp. 159-193, "Inositol-Trisphosphate and Diacylgycerol: Two Interacting Second Messengers", 1987.
Chan et al., Proc. Natl. Acad. Sci. USA, vol. 86, pp. 1756-1760, "Nerve Growth Factor Stimulates the Hydrolysis of Glycosylphosphatidylinositol in PC-12 Cells: A Mechanism of Protein Kinase C Regulation", 1989.
Curran et al., Cell, vol. 55, pp. 395-397, "Fos and Jun: The AP-1 Connection", 1988.
Curran, Tom, The Oncogene Handbook, Chapter 16, pp. 307-325, "The fos Ongogene", 1988.
Detmar et al., Clinical Research, vol. 38, No. 2, p. 645A, "TNF-Alpha But Not IL-6 Induces HLA-DR and ICAM-1 Expression in Cultured Dermal Microvascular Endothelial Cells. Anti-TNF AB and ZNSO.sub.4 Inhibit This Induction", 1990.
Eardley et al., Science, vol. 251, pp. 78-81, "Glycosylphosphatidylinositol: A Candidate System for Interleukin-2 Signal Transduction", 1991.
Gorog et al., Haemostasis, vol. 16, pp. 337-345, "Prostacyclin is a More Potent Stimulator of Thromobolysis than Inhibitor of Haemostasis", 1986.
Holler et al., Blood, vol. 75, No. 4, pp. 1011-1016, "Increased Serum Levels of Tumor Necrosis Factor-.alpha. Precede Major Complications of Bone Marrow Transplantation", 1990.
Irle et al., Bone Marrow Transplantation, vol. 1, (Supplement), p. 127, "Serum TNF Levels During Graft Versus Host Disease After Allogenic Bone Marrow Transplantation", 1988.
Kone et al., Quarterly Journal of Medicine, Series 69, No. 260, pp. 985-995, "Hypertension and Renal Dysfunction in Bone Marrow Transplant Recipients", 1988.
Maury et al., J. Exp. Med., vol. 166, p. 1132-1137, "Raised Serum Levels of Cachectin/Tumor Necrosis Factor-.alpha. in Renal Allograft Rejection", 1987.
Meunier, F., Reviews of Infectious Diseases, vol. 9, No. 2, pp. 408-416, "Prevention of Mycoses in Immunocompromised Patients", 1987.
Rivera, et al., The New Biologist, vol. 2, No. 9, pp. 751-758, "Growth Factor Induced Gene Expression: The Ups and Downs of fos Regulation", 1990.
Saltiel et al., The Journal of Biological Chemistry, vol. 262, No. 3, pp. 1116-1121, "Insulin-Stimulated Diacylglycerol Production Results from the Hydrolysis of a Novel Phosphatidylinositol Glycan", 1987.
Sheng et al., Neuron, vol. 4, pp. 477-485, "The Regulation and Function of c-fos and Other Immediate Early Genes in the Nervous System", 1990.
Storb, Rainer, Cancer Principles and Practices of Oncology, pp. 2474-2489, "Bone Marrow Transplantation", 1989.
te Velde et al., Blood, vol. 76, No. 7, pp. 1392-1397, "Interleukin-4 (IL-4) Inhibits Secretion of IL-1.beta., Tumor Necrosis Factor .alpha., and IL-6 by Human Monocytes", 1990.
Trahey et al., Science, vol. 238, pp. 542-545, "A Cytoplasmic Protein Stimulates Normal N-ras p21 GTPase, but Does Not Affect Oncogenic Mutants", 1987.
Widmer et al., J. Exp. Med., vol. 166, pp. 1447-1455, "Regulation of Cytolytic Cell Populations from Human Peripheral Blood by B Cell Stimulatory Factor 1 (Interleukin 4)", 1987.
Williams, Lewis T., Science, vol. 243, pp. 1564-1570, "Signal Transduction by the Platelet-Derived Growth Factor Receptor", 1989.
Zagar et al., American Journal of Kidney Disease, vol. 13, No. 3, pp. 210-216, "Acute Renal Failure Following Bone Marrow Transplantation: A Retrospective Study of 272 Patients", 1989.
Bailly et al., "Effects of Quinolones on Tumor Necrosis Factor Production By Human Monocytes", Int. J. Immunopharmac., vol. 12, No. 1, pp. 31-36, 1990.
Beutler et al., "Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin Resistance", Science, vol. 232, pp. 977-980, May 23, 1986.
Bevilacqua et al., "Recombinant Tumor Necrosis Factor Induces Procoagulant Activity In Cultured Human Vascular Endothelium: Characterization And Comparison With The Actions of Interleukin 1", Proc. Natl. Acad. Sci. USA, vol. 83, pp. 4533-4537, Jun. 1986.
Bianco et al., "Pentoxifylline (PTX) and GM-CSF Decrease Tumor Necrosis Factor-ALpha (TNF-.alpha.) Levels in Patients Undergoing Allogeneic Bone Marrow Transplantation (BMT)", Blood, vol. 76, Supplement (522), p. 133a, 1991.
Bianco et al., "Phase I-II Trail of Pentoxifylline for the Prevention of Transplant-Related Toxicities Following Bone Marrow Transplantation", Blood, vol. 78, No. 5, pp. 1205-1211, Sep. 1, 1991.
Crumplin, G. C., "Aspects of Chemistry in the Development of the 4-Quinolone Antibaterial Agents", Reviews of Infectious Diseases, vol. 10, (Supplement 1), pp. S2-S9, Jan.-Feb. 1988.
Davis et al., "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifylline", Applied and Environmental Microbiology, vol. 48, No. 2, pp. 327-331, Aug. 1984.
Francis et al., "Tissue Plasminogen Activator Antigen and Activity in Disseminated Intravascular Coagulation: Clinicopathologic Correlations", J. Lab. Clin. Med., vol. 110, pp. 541-547, Nov. 1987.
Han et al., "Dexamethasone and Pentoxifylline Inhibit Endotoxin-Induced Cachectin/Tumor Necrosis Factor Synthesis at Separate Points in the Signaling Pathway", J. Exp. Med., vol. 172, pp. 391-394, Jul. 1990.
Hinterberger et al., "Further Evidence for Lymphokine Overproduction in Severe Aplastic Anemia", Blood, vol. 72, No. 1, pp. 266-272, Jul. 1988.
Hooper et al., "Mode of Action of the Quinolone Antimicrobial Agents: Review of Recent Information", Reviews of Infectious Diseases, vol. II, (Supplement 5), pp. S902-S911, Jul.-Aug. 1989.
Kriegler et al., "A Novel Form of TNF/Cachectin Is a Cell Surface Cytotoxic Transmembrane Protein: Ramifications for the Complex Physiology of TNF
Bianco James A.
Bursten Stuart L.
Singer Jack W.
Faciszewski Stephen
Fred Hutchinson Cancer Research Center
Gitomer Ralph J.
LandOfFree
Modulation of cellular response to external stimuli does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of cellular response to external stimuli, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of cellular response to external stimuli will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991513